TREMONT STRATEGIES GROUP LLC for AMAG PHARMACEUTICAL
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2021 | $40,000 | Replaced |
| 4th Quarter - Amendment | Jan 22, 2021 | $40,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmaceutical issues; access to women's health pharmaceutical products.
Foreign entity interest: AMAG is owned by COVIS Pharma, headquartered in Luxembourg with a branch in Zug, Switzerland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID J GARRIEPY | — |
| LIESL GREBENSTEIN SHEEHAN | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| COVIS PHARMA | Luxembourg | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.